Canopy Growth Co. Expected to Post Q1 2025 Earnings of ($0.39) Per Share (NASDAQ:CGC)

Canopy Growth Co. (NASDAQ:CGC) – Research analysts at Atb Cap Markets boosted their Q1 2025 earnings per share estimates for shares of Canopy Growth in a research note issued to investors on Monday, July 22nd. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.39) per share for the quarter, up from their previous estimate of ($0.41). Atb Cap Markets has a “Hold” rating on the stock. The consensus estimate for Canopy Growth’s current full-year earnings is ($1.07) per share. Atb Cap Markets also issued estimates for Canopy Growth’s Q2 2025 earnings at ($0.37) EPS, Q3 2025 earnings at ($0.29) EPS, FY2025 earnings at ($1.33) EPS, FY2027 earnings at ($0.56) EPS, FY2028 earnings at ($0.40) EPS and FY2029 earnings at ($0.15) EPS.

Separately, Piper Sandler cut their price target on Canopy Growth from $3.00 to $2.00 and set an “underweight” rating for the company in a research note on Tuesday, July 9th.

Canopy Growth Stock Down 10.7 %

Shares of Canopy Growth stock opened at $7.32 on Thursday. Canopy Growth has a 1 year low of $2.76 and a 1 year high of $19.20. The stock has a 50-day moving average price of $7.61 and a 200 day moving average price of $6.60. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.58 and a quick ratio of 1.25.

Canopy Growth (NASDAQ:CGC) last announced its quarterly earnings data on Thursday, May 30th. The company reported ($0.28) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.05. The firm had revenue of $53.99 million during the quarter, compared to the consensus estimate of $52.71 million. Canopy Growth had a negative return on equity of 62.67% and a negative net margin of 185.77%.

Insider Activity

In other news, Director Willy Kruh sold 3,738 shares of the stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $9.94, for a total transaction of $37,155.72. Following the transaction, the director now owns 17,295 shares of the company’s stock, valued at approximately $171,912.30. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In the last quarter, insiders have sold 7,545 shares of company stock valued at $67,997. Insiders own 0.35% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Genesee Capital Advisors LLC increased its holdings in shares of Canopy Growth by 15.3% during the 2nd quarter. Genesee Capital Advisors LLC now owns 15,047 shares of the company’s stock valued at $97,000 after acquiring an additional 2,000 shares during the last quarter. Baader Bank Aktiengesellschaft grew its holdings in Canopy Growth by 137.3% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 135,275 shares of the company’s stock valued at $873,000 after buying an additional 78,275 shares during the last quarter. Virtu Financial LLC acquired a new stake in Canopy Growth in the 1st quarter valued at approximately $544,000. Tidal Investments LLC acquired a new stake in Canopy Growth in the 1st quarter valued at approximately $21,718,000. Finally, Murchinson Ltd. acquired a new stake in Canopy Growth in the 1st quarter valued at approximately $13,149,000. Institutional investors and hedge funds own 3.33% of the company’s stock.

About Canopy Growth

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products.